Traditional testing techniques for residual host cell DNA and mycoplasma contaminants fall short of the stringent requirements set by regulatory bodies
Ensure production quality for cell and gene therapy development and manufacturing
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.